P01857 (IGHG1_HUMAN) Homo sapiens (Human)

Immunoglobulin heavy constant gamma 1 UniProtKBInterProInteractive Modelling

399 aa; Sequence (Fasta) ; (Isoform 1)

Available Structures

173 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 …
1hzh
 Heteromer
P01834; 		1-328
1×NAG; 1×NAG;
Assess
Solution structure of human Immunoglobulin M
2rcj
 Heteromer
Q6PYX1; 		1-326
Assess
Structure of a membrane protein G
7wso
 Heteromer
P11912; P40259; 		120-371
Assess
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgIII…
3sgj
 Heteromer
P08637; 		109-327
2×NAG; 1×NAG; 1×NAG; 1×MLI;
Assess
Structure of FcgammaRI in complex with Fc reveals the importance of glycan recognition for high aff…
4x4m
 Heteromer
P12314; 		112-328
2×NAG;
Assess
Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma rec…
3ay4
 Heteromer
P08637; 		112-327
2×NAG; 1×NAG; 1×NAG;
Assess
CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
1e4k
 Heteromer
O75015; 		112-327
1×NAG; 1×NAG;
Assess
The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant
8dir
 Heteromer
P12314; 		114-328
2×NAG; 3×NA;
Assess
The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant
8dj7
 Heteromer
P12314; 		114-328
1×NAG; 1×NAG; 2×SO4;
Assess
The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant
8din
 Heteromer
P12314; 		114-328
2×NAG; 1×MG;
Assess
Crystal structure of nonfucosylated Fc Y296W mutant complexed with bis-glycosylated soluble form of…
5bw7
 Heteromer
P08637; 		113-327
1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×CL;
Assess
High-resolution crystal structure of Fc bound to its human receptor Fc-gamma-RI
4w4o
 Heteromer
P12314; 		115-328
2×NAG; 1×NAG; 1×NAG; 6×ZN; 9×ACT; 2×GOL;
Assess
IgG1 Fc-FcgammaRI ecd complex
4zne
 Heteromer
P12314; 		115-328
1×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 3×ZN;
Assess
CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEX…
1t89
 Heteromer
O75015; 		114-327
1×NAG; 1×NAG;
Assess
Complex of fcgammariia (CD32) and the FC of human IGG1
3ry6
 Heteromer
P12318; 		114-327
1×NDG; 1×NAG; 1×NDG; 4×GOL; 1×NAG;
Assess
Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII and …
3sgk
 Heteromer
P08637; 		115-327
2×NAG; 1×NAG; 1×NAG; 1×MLI;
Assess
Crystal structure of IIb selective Fc variant, Fc(V12), in complex with FcgRIIb
3wjl
 Heteromer
P31995; 		115-327
1×NAG; 1×NAG; 1×NAG;
Assess
CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORT…
1t83
 Heteromer
O75015; 		115-327
1×NAG; 1×NAG; 1×HG2;
Assess
Crystal structure of IIb selective Fc variant, Fc(P238D), in complex with FcgRIIb
3wjj
 Heteromer
P31994; 		116-327
2×NAG;
Assess
Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa
3wn5
 Heteromer
P08637; 		116-327
2×NAG; 1×NAG; 1×NAG; 7×IOD;
Assess
IgG Fc bound to 3 helix of the B-domain from Protein A
5u4y
 Heteromer
P02976; 		118-328
1×NAG; 1×NAG;
Assess
G-2 glycovariant of human IgG Fc bound to minimized version of Protein A called Z34C
1oqx
 Heteromer
119-328
1×NAG; 1×NAG;
Assess
Knob-into-hole IgG Fc
4nqs
 Heteromer
118-327
Assess
Crystal structure of the artificial protein AFFinger p17 (AF.p17) complexed with Fc fragment of hum…
3wkn
 Heteromer
119-328
2×NAG;
Assess
Crystal Structure of an Autoimmune Complex between a Human IgM Rheumatoid Factor and IgG1 Fc reveal…
2j6e
 Heteromer
119-328
2×NAG; 1×CD; 2×ZN; 1×CAC; 6×MPD; 4×ACT;
Assess
Complex between G0 version of an Fc bound to a minimized version of Protein A called Mini-Z
1oqo
 Heteromer
119-327
1×NAG; 1×NAG;
Assess
Crystal structure of GASDALIE IgG1 Fc in complex with FcgRIIIa
5d6d
 Heteromer
P08637; 		119-327
1×NAG; 1×NAG; 1×FUC; 2×NAG;
Assess
Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod)
7q15
 Heteromer
P55899; P61769; 		119-327
1×NAG; 1×NAG;
Assess
Ternary complex between Neonatal Fc receptor, serum albumin and Fc
4n0u
 Heteromer
P02768; P55899; P61769; 		119-327
2×NAG;
Assess
GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT
6yt7
 Heteromer
P0DOX5; 		120-327
2×NAG;
Assess
2 helix minimized version of the B-domain from Protein A (Z34C0 bound to IgG1 Fc (monoclinic form)
5u52
 Heteromer
119-326
2×NAG;
Assess
BEAT Fc
5m3v
 Heteromer
P01860; 		120-327
2×NAG;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19
5k33
 Heteromer
P04626; 		120-327
2×NAG; 2×NAG; 2×GOL; 4×NAG;
Assess
FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1l6x
 Heteromer
120-326
1×NAG;
Assess
Stable Effector Functionless 2 (SEFL2) IgG1 Fc Scaffold Bound to a Minimized Version of the B-domai…
7lur
 Heteromer
120-326
Assess
COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2iwg
 Heteromer
P19474; 		120-326
2×NAG; 2×FUC;
Assess
Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment …
1fc2
 Heteromer
P38507; 		121-327
2×NAG; 2×SO4;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6
5kwg
 Heteromer
P04626; 		120-326
Assess
Crystal Structure of a gE-gI/Fc complex
2gj7
 Heteromer
P04488; 		120-326
2×NAG;
Assess
CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HU…
1fcc
 Heteromer
P19909; 		121-326
Assess
Anti-beta-amyloid antibody c706 fab in space group P21
3mcl
 Heteromer
1-107
Assess
Crystal structure of the anti-human NGF Fab APE1531
4nwt
 Heteromer
Q8TCD0; 		1-104
2×MES; 4×ACT; 1×PGE;
Assess
Crystal structure of human anti-tau antibody CBTAU-27.1
6dcv
 Heteromer
P01834; 		1-104
2×GOL;
Assess
Crystal structure of NIH45-46 Fab
3u7w
 Heteromer
P01834; 		1-104
3×GOL; 1×SO4; 1×NAG;
Assess
Crystal structure of APE1551, an anti-human NGF Fab with a nine amino acid insertion in CDR H1
4nwu
 Heteromer
Q8TCD0; 		1-103
Assess
Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with Man9
3twc
 Heteromer
1-103
1×MAN; 1×AML;
Assess
THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID
1aqk
 Heteromer
P0DOY2; 		1-103
Assess
48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1gaf
 Heteromer
P01834; 		1-103
1×NPE;
Assess
TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
1vge
 Heteromer
1-103
Assess
IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2rcs
 Heteromer
1-103
Assess
IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PE…
1aj7
 Heteromer
1-103
1×NPE;
Assess
ANTIBODY GNC92H2 BOUND TO LIGAND
1i7z
 Heteromer
P01834; 		1-103
1×COC;
Assess
Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D
4d9r
 Heteromer
P00746; P01834; 		1-103
Assess
FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1hkl
 Heteromer
P01834; 		1-103
Assess
STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS …
1dfb
 Heteromer
P01834; 		1-103
Assess
Anti-beta-amyloid antibody c706 fab in space group c2
3o11
 Heteromer
P01834; 		1-103
Assess
Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A…
4xmp
 Heteromer
P01834; Q8JDI3; 		1-102
11×NAG; 2×BU3;
Assess
Germline 7G12 with N-methylmesoporphyrin
1n7m
 Heteromer
1-102
1×MMP;
Assess
Crystal structure of IL-23 in complex with neutralizing FAB
3d85
 Heteromer
P29460; Q9NPF7; 		1-102
1×IMD; 2×MPD;
Assess
Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade …
4xny
 Heteromer
P01834; Q8JDI3; 		1-102
11×NAG;
Assess
Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.
5iq7
 Heteromer
V9QIE5; 		1-102
Assess
Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with Man9
3tv3
 Heteromer
1-101
1×MAN; 4×GOL; 1×AML; 1×EPE;
Assess
Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 2 bet…
4llq
 Heteromer
P0DOY2; 		1-101
1×PG6;
Assess
Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1, CR…
4llm
 Heteromer
P0DOY2; 		1-101
Assess
Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007
4eow
 Heteromer
P0DOY2; 		1-101
Assess
Crystal structure of human anti-tau antibody CBTAU-27.1 Fab in complex with a human tau peptide
6dcw
 Heteromer
A0A2K5IAM2; P01834; 		1-101
Assess
CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
1d6v
 Heteromer
P01834; 		1-101
4×CD; 1×HOP;
Assess
UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
1d5i
 Heteromer
P01834; 		1-101
3×CD;
Assess
Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide
4hix
 Heteromer
P01834; P05067; 		1-101
Assess
Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D
4d9q
 Heteromer
F6YBP7; Q8TCD0; 		1-101
3×GOL; 4×ZN; 2×SO4;
Assess
Crystal structure of 10E8v4 Fab in complex with an HIV-1 gp41 peptide.
5iq9
 Heteromer
Q1HSF8; 		1-101
Assess
Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV
3u7y
 Heteromer
A0A0M3KKW9; P01834; 		1-101
1×NAG; 1×FLC; 6×NAG; 1×CL;
Assess
MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1axs
 Heteromer
Q7Z3Y4; 		1-101
5×CD; 1×HOP;
Assess
UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
1d5b
 Heteromer
P01834; 		1-101
1×CD;
Assess
Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosyl…
3tyg
 Heteromer
P04578; P0DOY2; Q75760; 		1-101
1×NAG; 1×NAG;
Assess
Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade …
4xnz
 Heteromer
P01834; Q0ED31; 		1-101
1×NAG; 6×NAG;
Assess
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12…
5c7k
 Heteromer
P01834; Q2N0S6; S6B291; 		1-101
12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4;
Assess
AD related murine antibody Fragment
3u0w
 Heteromer
P01647; P01808; P01834; 		1-100
Assess
Crystal Structure of mid-region amyloid beta capture by solanezumab
4xxd
 Heteromer
P01834; P05067; 		1-100
Assess
Murine 6A6 Fab in complex with humanized anti-Tissue Factor D3H44 Fab
1pg7
 Heteromer
G0YP42; P01863; Q7Z3Y4; 		1-100
Assess
Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T…
6de7
 Heteromer
P04578; P0DOY2; Q2N0S6; 		1-100
6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4;
Assess
Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constant …
4lld
 Heteromer
P0DOY2; 		3-101
Assess
Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneum…
4dag
 Heteromer
G3KCK8; Q8N5F4; 		1-98
2×NAG;
Assess
BEAT Fc with improved heterodimerization (Q3A-D84.4Q)
6g1e
 Heteromer
P01860; P0DOX5; 		120-156
2×NAG;
Assess
Crystal structure of the anti-hinge rabbit antibody 2095-2 in complex with IDES hinge peptide
4o4y
 Heteromer
113-119
5×GOL;
Assess
Crystal structure of the QAA variant of anti-hinge rabbit antibody 2095-2 in complex with IDES hing…
4o51
 Heteromer
114-119
Assess
Crystal structure of a human IgG1 Fc-fragment,high salt condition
1h3y
homo-4-mer121-327
2×NAG; 2×NAG;
Assess
Crystal structure of IgG1-Fc-MST-HN (efgartigimod)
7q3p
homo-3-mer119-328
2×NAG; 1×NAG; 2×MAN; 1×NAG; 4×NAG; 1×BMA; 2×MAN; 1×FUC;
Assess
Engineered human IgG Fc domain glyco801 (Fc801)
5v4e
homo-2-mer110-327
1×NAG; 1×K; 2×MAN; 1×NAG;
Assess
F241A Fc
4q74
homo-2-mer113-326
1×NAG; 1×NAG;
Assess
Fc K392D/K409D homodimer
5dvo
homo-2-mer117-328
2×SO4;
Assess
Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1
3ave
homo-2-mer117-327
2×NAG; 1×ZN;
Assess
Crystal Structure of the Defucosylated Fc Fragment from Human Immunoglobulin G1
2dts
homo-2-mer117-327
1×NAG; 1×NAG;
Assess
Heterodimeric Fc Antibody Azymetric Variant 1
4bsv
homo-2-mer119-328
1×NAG; 1×NAG; 1×MAN; 1×NAG; 9×EDO; 3×IOD;
Assess
Heterodimeric Fc Antibody Azymetric Variant 2
4bsw
homo-2-mer119-328
2×NAG; 5×EDO; 3×IOD;
Assess
Fc fragment of IgG1 (Herceptin) with protein-A mimetic peptide dendrimer ligand.
3d6g
homo-2-mer119-328
2×NAG; 1×X12;
Assess
Structural Characterization of a Human Fc Fragment Engineered for Lack of Effector Functions
3c2s
homo-2-mer119-328
2×NAG; 8×ZN;
Assess
Crystal structure of VEGF binding IgG1-Fc (Fcab CT6)
5k65
homo-2-mer119-328
1×NAG; 1×NAG;
Assess
Human 1gG1 Fc fragment, 2.5 Angstrom structure
3do3
homo-2-mer119-328
2×NAG;
Assess
Crystal structure of monoclonal human anti-rhesus D Fc and IgG1 t125(yb2/0) in the presence of EDTA
3v95
homo-2-mer119-328
2×NAG; 2×GOL;
Assess
Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant (H310 and H43…
3v8c
homo-2-mer119-328
1×MAN; 7×NAG; 3×GOL; 5×MAN; 2×GAL;
Assess
Enzyme deglycosylated Human IgG1 Fc fragment
3dnk
homo-2-mer119-328
Assess
Glycosylated, disulfide-linked Hole-Hole Fc fragment
5hyi
homo-2-mer119-328
2×NAG;
Assess
Glycosylated Knob-Knob Fc fragment (P6122)
5hyf
homo-2-mer118-326
2×NAG;
Assess
Fc Heterodimer Design 7.8 D399M/Y407A + T366V/K409V
5djz
homo-2-mer118-326
1×NAG;
Assess
human IgG1 Fc fragment Heterodimer
4dz8
homo-2-mer119-327
2×NAG;
Assess
Crystal structure of monoclonal human anti-Rhesus D Fc IgG1 T125(YB2/0) in the presence of Zn2+
3v7m
homo-2-mer119-327
2×NAG; 6×ZN; 6×IMD; 2×GOL;
Assess
Crystal structure of sialylated IgG Fc
4byh
homo-2-mer119-327
1×NAG; 1×NAG; 2×CL;
Assess
Engineered human IgG Fc domain aglyco801
5v43
homo-2-mer119-327
Assess
anti-CD20 monoclonal antibody Fc fragment
5iw6
homo-2-mer119-327
2×NAG;
Assess
Wild type Fc (wtFc)
4q7d
homo-2-mer119-327
2×NAG;
Assess
Crystal structure of a human Fc fragment engineered for extended serum half-life
3fjt
homo-2-mer119-327
2×NAG;
Assess
Crystal Structure of an IgG1 Fc Glycoform (Man9GlcNAc2)
2wah
homo-2-mer120-328
1×NAG; 1×NAG;
Assess
Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragment
2ql1
homo-2-mer119-327
2×NAG; 8×ZN;
Assess
Crystal structure of a chemoenzymatic glycoengineered disialylated Fc (di-sFc)
4q6y
homo-2-mer119-327
1×NAG; 1×NAG;
Assess
Crystal structure of human IgG1-Fc
5jii
homo-2-mer120-327
1×NAG; 1×NAG; 2×PO4; 3×GOL;
Assess
Crystal structure of IgG Fc with a homogeneous glycoform and Antibody-Dependent Cellular Cytotoxici…
5gsq
homo-2-mer120-327
2×NAG;
Assess
Glycosylated Knob-Knob Fc fragment (P212121)
5hye
homo-2-mer119-326
2×NAG;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H435A
4wi7
homo-2-mer120-327
2×NAG; 2×EDO;
Assess
Fc Design 20.8.37 A chain homodimer Y349S/T366M/K370Y/K409V
5dvl
homo-2-mer120-327
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc (wild-type)
4wi2
homo-2-mer120-327
2×NAG; 3×EDO;
Assess
Fc Knob-Hole Heterodimer T366W + T366S/L368A/Y407V
5di8
homo-2-mer120-327
2×NAG;
Assess
Role of the hinge and C-gamma-2/C-gamma-3 interface in immunoglobin G1 Fc domain motions: implicati…
4ku1
homo-2-mer120-327
1×NAG; 1×NAG; 1×PG4;
Assess
Fc Heterodimer Design 6.1 F405W/Y407A + T366M
5dj6
homo-2-mer120-327
2×NAG;
Assess
anti-CD20 monoclonal antibody Fc fragment
5iw3
homo-2-mer119-326
2×NAG; 6×SO4; 4×ACT;
Assess
anti-parallel Fc-hole(T366S/L368A/Y407V) homodimer
4nqt
homo-2-mer120-327
Assess
Fc Heterodimer Design 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
5djy
homo-2-mer120-327
2×NAG;
Assess
Crystal structure of a human IgG-aptamer complex
3agv
homo-2-mer120-327
1×MAN; 1×NDG; 2×CA;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation N434A
4wi6
homo-2-mer120-327
2×NAG; 2×EDO;
Assess
Fc Heterodimer Design 2.9 L368M/K370E + E357A/S364G
5djx
homo-2-mer120-327
2×NAG;
Assess
Fc Heterodimer Design 11.2 Y349S/K370Y + E357D/S364Q
5dj0
homo-2-mer120-327
2×NAG;
Assess
Crystallographic structure of the Human Igg1 alpha 2-6 sialilated Fc-Fragment
4cdh
homo-2-mer119-326
1×NAG; 1×NAG;
Assess
Fc Heterodimer Design 5.1 T366V + Y407F
5djd
homo-2-mer120-327
2×NAG;
Assess
Crystal Structure of Human IgG Fc Bearing Hybrid-type Glycans
4b7i
homo-2-mer120-327
1×NAG; 1×CL;
Assess
Crystal structure of GASDALIE IgG1 Fc
5d4q
homo-2-mer120-327
2×NAG; 1×FUC;
Assess
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2
1h3u
homo-2-mer121-328
1×NAG; 1×NAG;
Assess
Crystal structure of the human igg1 fc-fragment,glycoform (mn2f)2
1h3t
homo-2-mer121-328
1×NAG; 1×BMA;
Assess
Fc Heterodimer Design 7.7 D399M/Y407A + T366V/K409I
5dj8
homo-2-mer120-327
2×NAG;
Assess
Crystal structure of VEGF binding IgG1-Fc (Fcab 448)
5k64
homo-2-mer119-326
1×NAG; 1×NAG; 3×GOL; 1×MES;
Assess
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2
1h3x
homo-2-mer121-328
2×NAG;
Assess
Deactivation of human IgG1 Fc by endoglycosidase treatment
4acp
homo-2-mer120-327
1×NAG;
Assess
Immunoglobulin Fc heterodimers variant
4x99
homo-2-mer120-327
2×NAG;
Assess
Immunoglobulin Fc heterodimer variant
4x98
homo-2-mer120-327
2×NAG;
Assess
anti-parallel Fc-knob (T366W) homodimer
4nqu
homo-2-mer120-327
2×SO4;
Assess
Fc K392D/K409D homodimer
5dvn
homo-2-mer120-327
Assess
Fc Heterodimer Design 7.4 Y407A + T366V/K409V
5dj2
homo-2-mer120-327
2×NAG;
Assess
Fc Heterodimer E356K/D399K + K392D/K409D
5dk2
homo-2-mer119-326
2×NAG;
Assess
Fc Design 7.7 B chain homodimer T366V/K409I
5dvk
homo-2-mer120-327
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A/H310A
4wi9
homo-2-mer120-327
1×NAG; 1×NAG; 1×NAG;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A
4wi3
homo-2-mer120-327
2×NAG;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310A
4wi5
homo-2-mer120-327
2×NAG; 3×EDO;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation Y436A
4wi8
homo-2-mer120-327
1×NAG; 1×NAG; 1×BMA;
Assess
Fc Heterodimer Design 9.1 Y407M + T366I
5dja
homo-2-mer120-327
2×NAG;
Assess
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121
1h3v
homo-2-mer121-328
1×NAG; 1×NAG;
Assess
Aglycosylated human igg1 fc fragment
3s7g
homo-2-mer119-326
Assess
Crystal structure of HER2 binding IgG1-Fc (Fcab STAB19)
5jih
homo-2-mer120-326
1×NAG; 1×NAG;
Assess
Modified single helix from the B-domain of protein A bound to IgG1 Fc
5u66
homo-2-mer120-326
2×NAG;
Assess
Crystal structure of human Fc at 1.80 A
4w4n
homo-2-mer120-326
1×NAG; 1×NAG; 1×GOL;
Assess
Crystal structure of HER2 binding IgG1-Fc (Fcab H10-03-6)
5jik
homo-2-mer120-326
1×NAG; 1×NAG;
Assess
Fc Heterodimer Design 8.1 L368V/Y407A + T366V/K409F
5djc
homo-2-mer120-326
2×NAG;
Assess
Fc Heterodimer Design 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
5dk0
homo-2-mer120-326
2×NAG;
Assess
Structure of a Fc heterodimer
5tps
homo-2-mer121-327
1×NAG; 1×NAG;
Assess
FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
1dn2
homo-2-mer120-326
1×NAG; 1×NAG;
Assess
Glycosylated, disulfide-linked Knob-into-Hole Fc fragment
5hy9
homo-2-mer120-326
1×NAG; 1×NAG;
Assess
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation S254A
4wi4
homo-2-mer121-327
2×NAG; 3×EDO;
Assess
CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT …
1fc1
homo-2-mer121-327
2×NAG;
Assess
Fc Design 20.8.37 B chain homodimer E357D/S364R/Y407A
5dvm
homo-2-mer120-326
Assess
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and stru…
1h3w
homo-2-mer121-326
2×NAG;
Assess
1.52 Angstrom Crystal Structure of Fc fragment of Human IgG1.
5hsf
homo-2-mer221-328
2×PGE;
Assess
monomeric Fc
4j12
monomer119-327
1×NAG; 1×NAG;
Assess
Structure of a Fc mutant
6f2z
monomer120-327
1×NAG;
Assess
Crystal Structure of IgG Fc F241A mutant with native glycosylation
4bm7
monomer120-326
1×NAG; 1×CL;
Assess
Crystal Structure of an isolated, unglycosylated antibody CH2 domain
3dj9
monomer119-225
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5vh5.1.Bhomo-2-mer0.86121-327
2×ZN;89.34
Assess
6gfe.1.Bmonomer0.824-327
91.93
Assess
6gfe.1.Amonomer0.814-327
91.93
Assess
6hyg.1.Amonomer0.774-327
1×ZN;72.00
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 15vh5.1.Bhomo-2-mer0.86121-327
2×ZN;89.43
Assess
Isoform 16gfe.1.Amonomer0.811-327
91.13
Assess
Isoform 16gfe.1.Bmonomer0.811-327
91.13
Assess
Isoform 16hyg.1.Amonomer0.774-327
1×ZN;74.69
Assess